🔎 Trials Near Me

Početna › Multipla skleroza › Georgia

Kliničke studije za Multipla skleroza u državi Georgia

7 studija za Multipla skleroza traži sudionike na lokacijama u državi Georgia.

Gradovi u državi Georgia

Službeni tekst studije (engleski)

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  • Atlanta Neuroscience Institute, Atlanta
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07609719

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 102, Atlanta
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07840326

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Atlanta
  • TG Therapeutics Investigational Trial Site, Atlanta
  • TG Therapeutics Investigational Trial Site, Savannah
  • i još 1
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Emory University, Atlanta
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Joi Life Wellness Group LLC- Site Number : 8400192, Smyrna
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07325292

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Joi Life Wellness Group LLC, Smyrna
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07225504

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

  • Emory Univeristy, Atlanta
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 89 godina · Oba spola · Ažurirano 16. srp 2025. · NCT06495138

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.